Sage Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 05/09/2025 | 5.08 M | $40.36 M | 4.94% | 8.21% |
BLACKROCK, INC. | 05/02/2025 | 4.66 M | $37.06 M | -3.91% | 7.54% |
MADISON AVENUE PARTNERS, LP | 05/15/2025 | 4.48 M | $35.60 M | 100.00% | 7.24% |
CALIGAN PARTNERS LP | 05/15/2025 | 3.05 M | $24.27 M | 0.00% | 4.93% |
TIG ADVISORS, LLC | 05/15/2025 | 2.73 M | $21.72 M | 100.00% | 4.42% |
D. E. SHAW & CO., INC. | 05/15/2025 | 2.09 M | $16.60 M | 189.88% | 3.37% |
DEEP TRACK CAPITAL, LP | 05/15/2025 | 2.04 M | $16.21 M | 100.00% | 3.30% |
MARSHALL WACE, LLP | 05/15/2025 | 1.76 M | $14.01 M | 100.00% | 2.85% |
MORGAN STANLEY | 05/15/2025 | 1.40 M | $11.12 M | -69.55% | 2.26% |
BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 1.38 M | $11.01 M | -0.29% | 2.24% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.30 M | $10.36 M | 3.70% | 2.11% |
FEDERATED HERMES, INC. | 05/08/2025 | 1.19 M | $9.48 M | 7.84% | 1.93% |
STATE STREET CORP | 05/15/2025 | 1.19 M | $9.45 M | -6.61% | 1.92% |
AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 1.15 M | $9.11 M | 104.55% | 1.85% |
CITADEL ADVISORS LLC | 05/15/2025 | 1.05 M | $8.34 M | 1,144.28% | 1.70% |
683 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 1.00 M | $7.95 M | 58.73% | 1.62% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 769.70 K | $6.12 M | 70.74% | 1.24% |
ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 742.50 K | $5.90 M | 3,767.16% | 1.20% |
HARVEST MANAGEMENT LLC | 05/15/2025 | 726.20 K | $5.77 M | 100.00% | 1.17% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2025 | 706.39 K | $5.62 M | -37.12% | 1.14% |
BOUSSARD & GAVAUDAN INVESTMENT MANAGEMENT LLP | 05/15/2025 | 655.66 K | $5.25 B | 100.00% | 1.06% |
TREXQUANT INVESTMENT LP | 05/14/2025 | 633.63 K | $5.04 M | 338.00% | 1.02% |
05/12/2025 | 598.31 K | $4.76 M | 100.00% | 0.97% | |
HUDSON BAY CAPITAL MANAGEMENT LP | 05/14/2025 | 579.57 K | $4.61 M | 134.64% | 0.94% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 481.78 K | $3.83 M | -0.74% | 0.78% |
NORTHERN TRUST CORP | 05/13/2025 | 468.06 K | $3.72 M | -10.75% | 0.76% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 446.18 K | $3.55 M | -3.49% | 0.72% |
MONACO ASSET MANAGEMENT SAM | 05/08/2025 | 441.62 K | $3.51 M | 100.00% | 0.71% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 438.05 K | $3.48 M | -19.22% | 0.71% |
05/14/2025 | 384.69 K | $3.06 M | 100.00% | 0.62% | |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 358.39 K | $2.85 M | 176.21% | 0.58% |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 325.00 K | $2.58 M | 175.89% | 0.53% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 309.54 K | $2.46 M | -80.94% | 0.50% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 231.10 K | $1.84 M | 292.36% | 0.37% |
DEUTSCHE BANK AG\ | 05/09/2025 | 223.98 K | $1.78 M | 340.75% | 0.36% |
PINNACLE ASSOCIATES LTD | 05/06/2025 | 218.34 K | $1.74 M | -0.84% | 0.35% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 05/14/2025 | 211.56 K | $1.68 M | -2.00% | 0.34% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 204.00 K | $1.62 M | -35.58% | 0.33% |
GOVERNORS LANE LP | 05/15/2025 | 202.40 K | $1.61 B | 100.00% | 0.33% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 199.99 K | $1.59 M | 170.80% | 0.32% |
JUMP FINANCIAL, LLC | 05/14/2025 | 188.60 K | $1.50 M | 100.00% | 0.30% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/12/2025 | 187.05 K | $1.49 M | 10.64% | 0.30% |
05/15/2025 | 183.47 K | $1.46 M | 100.00% | 0.30% | |
ALPINE GLOBAL MANAGEMENT, LLC | 05/15/2025 | 180.00 K | $1.43 M | 100.00% | 0.29% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 172.73 K | $1.37 M | 0.75% | 0.28% |
VERITION FUND MANAGEMENT LLC | 05/15/2025 | 172.02 K | $1.37 M | 1.78% | 0.28% |
05/14/2025 | 170.00 K | $1.35 M | 100.00% | 0.27% | |
IEQ CAPITAL, LLC | 05/14/2025 | 164.65 K | $1.31 M | 1,472.90% | 0.27% |
INVESCO LTD. | 05/12/2025 | 162.49 K | $1.29 M | 75.62% | 0.26% |
HRT FINANCIAL LP | 05/15/2025 | 150.32 K | $1.20 M | -0.34% | 0.24% |
Sage Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 309 institutional investors and hedge funds held shares of Sage Therapeutics, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 5.08 M
BlackRock, Inc.: 4.66 M
Madison Avenue Partners, LP: 4.48 M
Caligan Partners LP: 3.05 M
TIG Advisors, LLC: 2.73 M
D. E. Shaw & Co., Inc.: 2.09 M
83.50% of Sage Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 71.24 M shares in the last 24 months. This purchase volume represents approximately $460.18 M in transactions.